Episode 273: Recap of 2020 with Drs. Sarah Read, M. Ali Khan and Ajay Kuriyan

Drs. Sarah Read, M. Ali Khan and Ajay Kuriyan join to recap the tumultuous 2020 year, covering COVID-19, major retina trial results, and coding/administrative changes.

Financial Disclosures: Dr. Sridhar is a consultant for Regeneron. Dr. Kuriyan is a consultant for Regeneron and Novartis and has received research funding from Regeneron. Dr. Read is a consultant for Genentech. Dr. Khan is a consultant for Allergan.

CME Information

Release: December 28, 2020; expires December 28, 2023

Reviewers: Purnima Patel, MD; Shriji Patel, MD; Carl Danzig, MD

Disclosures: The physician reviewers and Academy staff report no relevant financial disclosures.

Learning Objective: Upon completion of this episode, the listener should be able to describe evolving standards of care for the management of vitreoretinal disorders or the outcomes from recent research and how these impact patient care decisions.

Audience: This activity is intended for retina subspecialists and comprehensive ophthalmologists.

Accreditation: The American Academy of Ophthalmology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The American Academy of Ophthalmology designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits.^TM Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Hardware/Software Requirements: This learning activity requires a current web browser and speaker or headset capable of playing streaming audio.